Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
12/2005
12/06/2005US6972283 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
12/06/2005CA2349338C Novel macrolide antibiotics
12/06/2005CA2235942C Tricyclic erythromycin derivatives
12/06/2005CA2013524C Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
12/01/2005WO2005112951A1 Antitumor agent, method of producing antitumor agent, medicinal composition containing antitumor agent and microorganism producing antitumor agent
12/01/2005WO2005085266A8 Macrocyclic compounds and methods of making and using the same
12/01/2005WO2005053650A8 Azithromycin dosage forms with reduced side effects
12/01/2005US20050267054 Antibacterial compounds with improved pharmacokinetic profiles
12/01/2005US20050267052 Procyanidins as antineoplastic agents; topolisomerase, cylooxygenase, and/or lipoxygenase inhibitors; nitric oxide synthase modulators; hypotensive agents
12/01/2005US20050266523 Glycorandomization and the production of novel erythronolide and coumarin analogs
12/01/2005CA2776682A1 Tiacumicin b compound
11/2005
11/30/2005EP1600454A1 Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside
11/30/2005EP1600161A2 Processes for preparing 13-deoxyanthracycline derivatives as anticancer of low cardio toxicity
11/30/2005EP1599491A1 Bifunctional heterocyclic compounds and methods of making and using the same
11/29/2005CA2500217C Crystal forms of azithromycin
11/24/2005WO2005111055A1 Novel antibiotic kigamicins and use thereof
11/24/2005US20050261320 Compounds and methods for the treatment of cancer
11/24/2005US20050261206 chemical intermediates to derivatives such as 3-(beta -D-Glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole; treatment of diabetes or obesity; inhibit SGLT2 (Na+/glucose cotransporter 2)
11/24/2005US20050261205 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
11/23/2005EP1284983B1 Method used for transforming the carbonyl function in position 4'' of a cladinose unit of an aza macrolide into an amine derivative
11/23/2005EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition
11/23/2005EP0988309B1 C-4''-substituted macrolide derivatives
11/23/2005EP0871760B1 Recombinant production of novel polyketides
11/23/2005CN1699393A Flavonoid glycoside compound and its preparing process
11/23/2005CN1699392A Process for preparing total glucosides of picrorhiza rhizome
11/23/2005CN1699390A New C-glycoside derivation and its titivating use
11/17/2005WO2005108414A1 Crystalline forms of 9-(s)-erythromycylamine
11/17/2005WO2005108413A1 Carbamate linked macrolides useful for the treatment of microbial infections
11/17/2005WO2005108412A1 Ester linked macrolides useful for the treatment of microbial infections
11/17/2005WO2005081821A3 Polymorphic forms of 6-11 bicyclic ketolide derivatives
11/17/2005WO2005070427A8 Compounds for the sustained reduction of body weight
11/17/2005WO2005012242A3 Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256064 9-Desoxoerythromycin compounds as prokinetic agents
11/17/2005US20050256063 Crystal forms of azithromycin
11/17/2005US20050256062 A tablet of a crystalline form of azithromycin sesquihydrate or crystalline azithromycin monohydrate hemi-isopropanol solvate and a carrier or diluent; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of humans, mammals, birds, fish; drug resistance
11/17/2005CA2566112A1 Carbamate linked macrolides useful for the treatment of microbial infections
11/17/2005CA2566085A1 Ester linked macrolides useful for the treatment of microbial infections
11/17/2005CA2565588A1 Crystalline forms of 9-(s)-erythromycylamine
11/16/2005EP1594878A1 Avermectin monosaccharide derivatives having pesticidal properties
11/16/2005EP1594762A1 Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container
11/16/2005EP1511395A4 Method of extracting rutin from buck wheat growed by hydroponics
11/16/2005EP1066832B1 Preventives and remedies for ischemic reflow disorder
11/16/2005EP1007530B1 6-o-substituted erythromycin compounds and method for making same
11/16/2005CN1696143A Method for separating and purifying erythromycin
11/16/2005CN1696142A Method for producing puerarin in high purity and aglycon of soybean jointly
11/16/2005CN1227258C Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
11/10/2005WO2005105821A2 Process for the preparation of telithromycin
11/10/2005WO2005067564A3 6-11 bicyclic erythromycin derivatives
11/10/2005WO2005034846A3 Withanamide and withanolide compositions and method of use thereof
11/10/2005US20050250739 for treating neurological diseases including Parkinson's and related diseases; Hydrophilic transportable N-linked glycosyl dopaminergic prodrug compounds
11/10/2005US20050250714 Crystalline forms of 9-(S)-erythromycylamine
11/10/2005US20050250713 11,12-Cyclic thiocarbamate macrolide antibacterial agents
11/10/2005US20050250712 Single dose azithromycin
11/10/2005CA2559281A1 Process for the preparation of telithromycin
11/09/2005EP1592701A1 Avermectins and avermectin monosaccharides substituted in the 4'- and 4''- position having pesticidal properties
11/09/2005EP1592700A2 Avermectin- and avermectin monosaccharide derivatives substituted in the 4''- or 4'- position having pesticidal properties
11/09/2005EP1592699A1 AVERMECTIN AND AVERMECTIN MONOSACCHARIDE DERIVATIVES SUBSTITUTED IN THE 4”- OR 4’-POSITION HAVING PESTICIDAL PROPERTIES
11/09/2005EP1318201B1 Process for producing purified anthocyanin and crystalline anthocyanin
11/09/2005CN1226301C Preparation of 1,2-diacyl-3(6-deoxy-6-sulfo-alpha-D-glucopyranosyl)-sn-glycerin ester
11/09/2005CN1226297C Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same
11/03/2005WO2005070113A3 9n-substituted 6-11 bicyclic erythromycin derivatives
11/03/2005US20050245735 Neutral glycosphingolipids and glycosyl-sphingosines and methods for isolating the same
11/03/2005US20050245598 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein
11/03/2005US20050245469 Crystal forms of azithromycin
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/02/2005EP1590358A1 9-ketospinosyn derivatives
11/02/2005CN1692123A Compounds, compositions and methods for treatment of inflammatory diseases and conditions
11/02/2005CN1690070A Process for preparing important intermediate of macrolides antibiotic
11/02/2005CN1225470C Method for extracting icariine from epimedium plant
11/01/2005US6960453 Genetically engineered microorganisms yield up to 10-fold more non-natural analogues of polyketides; produce precociously in growing culture, not only during transition from growth to stationary phase
11/01/2005CA2281496C New hydroxy derivatives of tylosin and process for their preparation
10/2005
10/27/2005WO2005072204A3 6,11-3c-bicyclic 8a-azalide derivatives
10/27/2005WO2004110255A3 Antineoplastic agents targeted via glut transporters
10/27/2005US20050239741 use in the field of neuroprotection and cancer treatment (neuroblastoma tumors)
10/26/2005EP1589023A1 Oligosaccharide derivative
10/26/2005EP1589017A2 12,13-modified epothilone derivatives
10/26/2005EP1589010A1 New C-Glycoside derivatives and uses thereof
10/26/2005EP1588702A1 Azalide antibiotics for the topical treatment or prevention of ocular infections
10/26/2005EP1587480A2 Polyhydroxylated pyrrolizidine
10/26/2005EP1408047B1 Process for preparation of erythromycin compounds
10/26/2005EP1328236A4 Methods of decreasing or preventing pain using spicamycin derivatives
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005CN1688707A Tiacumicin production
10/26/2005CN1688597A Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
10/26/2005CN1688596A Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
10/26/2005CN1687099A Extractive of general flavone from blackberry lily, preparation method and application in preparing medication
10/26/2005CN1687098A Extractive of fingerprint characteristic component from skullcap root, extracting technique and application
10/26/2005CN1687097A Extractive from specific part of skullcap, preparation method and application
10/26/2005CN1224626C Beta-D-5-thioxylose derivatives, preparation method and therapeutic use
10/25/2005US6958156 Bioavailability, solubility; dietetic adjuvant, foods, cosmetics
10/25/2005CA2359708C Ketolide antibiotics
10/20/2005WO2005097106A1 Purifications of ellagitannins
10/20/2005WO2004028481A3 Nucleoside derivatives for treating hepatitis c virus infection
10/20/2005WO2003106413A3 Process for the preparation of oxazolidinones and method of use thereof
10/20/2005US20050233982 Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
10/20/2005US20050233431 Antibiotics; thioesterases; host cells
10/19/2005EP1585753A2 Novel semisynthetic macrolide antibiotics of the azalide series
10/19/2005EP0983348B1 Polyketides and their synthesis and use
10/19/2005CN1683386A Method for extracting vitexin, use and preparation
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 117